---
title: "Healthcare Communication Standards: HL7 FHIR vs Legacy Systems — Build or Buy Decision Guide 2026"
site: "hygiea.tech"
kind: "article"
author: "Dr. Nadia Petrov"
date: "November 19, 2026"
canonical: "https://hygiea.tech/blog/healthcare-communication-standards-hl7-fhir-vs-legacy-systems-build-or-buy-decision-guide-2026.php"
markdown: "https://hygiea.tech/blog/healthcare-communication-standards-hl7-fhir-vs-legacy-systems-build-or-buy-decision-guide-2026.php/index.md"
description: "Takeaway Detail Communication failure is the leading safety and cost risk in healthcare The Communicating for Safety Standard identifies accurate and timely exc"
---

# Healthcare Communication Standards: HL7 FHIR vs Legacy Systems — Build or Buy Decision Guide 2026

Dr. Nadia Petrov · November 19, 2026

> Takeaway Detail Communication failure is the leading safety and cost risk in healthcare The Communicating for Safety Standard identifies accurate and timely exc

| Takeaway | Detail |
| --- | --- |
| Communication failure is the leading safety and cost risk in healthcare | The Communicating for Safety Standard identifies accurate and timely exchange as critical; failure directly endangers patients |
| Poor communication costs clinics thousands annually | Curogram reports that poor communication can cost clinics thousands of dollars per year in avoidable losses |
| Fragmented clinical communication drives revenue leakage and malpractice risk | ClinicianCore documents that fragmentation causes financial losses, revenue leakage, and increased malpractice exposure |
| Build/buy choice depends on legacy endpoint test thresholds | Buy an interface engine and build only mapping/test pack when any legacy endpoint remains; do not custom-build a FHIR gateway unless the test pack shows ≤2% field failure |

This guide delivers a build-or-buy decision framework for 2026 ambulatory and lab leaders navigating HL7 FHIR integration with legacy systems.

As the takeaways table above states, the recommended choice is to buy a tested interface engine and build only the mapping and 20-message test pack when any legacy endpoint remains active; the sections below show how the endpoint inventory and test pack make that rule operational.

![Healthcare Communication Standards](https://static.mm-ais.com/article-images-ai/healthcare-communication-standards-hl7-f-ai-590d87f4.jpg)

## How FHIR and Legacy Interfaces Move Data

Every clinical message your organization sends has four named parts, and if any one of them is unnamed, the message is not actually integrated. Name the sender system (the EHR, lab information system, or reference lab portal that originates the result). Name the trigger event (order placed, specimen collected, result verified, result corrected). Name the transport — either a FHIR API call or a legacy feed such as an HL7 v2 message over an interface connection. Name the receiver acknowledgment (the specific system and the specific response that confirms receipt and acceptance). The Australian Commission on Safety and Quality in Health Care's Communicating for Safety Standard, updated April 29, 2026, frames the goal as accurate, timely exchange of information about a person's care between health professionals, multidisciplinary teams, and patients and their support people. That definition is a useful audit lens: a message with no named acknowledgment is not an exchange, it is a broadcast.

Treat FHIR as an API contract and legacy as a feed contract. The build/buy question is not which label sounds modern; it is which contract has a named owner, a test pack, and a fallback path. A FHIR API contract specifies the resource, the search parameters, the authentication method, and the error response the receiver returns. A legacy feed contract specifies the message type, the segment and field positions, the encoding characters, and the acknowledgment message the receiver sends back. Both are contracts. Neither is self-documenting, and neither survives a vendor upgrade without an owner who can read it.

Build the sender-transport-receiver map before you evaluate any product. For each interface in scope, write one row with the four parts above plus the acknowledgment test point — the exact step where you will confirm the receiver accepted the message rather than merely received it. A practical test point for a legacy feed is the application acknowledgment returned by the receiving system; for a FHIR exchange it is the response status and body returned by the receiving endpoint. If you cannot point to the artifact that proves acceptance, you have a transport, not an interface.

| Part | What to name | What to verify |
| --- | --- | --- |
| Sender system | Originating application and its owner | Owner is a named person, not a team inbox |
| Trigger event | Order, collection, verification, correction | Corrections are mapped, not just first results |
| Transport | FHIR API or legacy feed | Contract documented with version and encoding |
| Receiver acknowledgment | Receiving system and response type | Acknowledgment test point is defined and run |

Require the acknowledgment test point to be exercised with a deliberately malformed or out-of-sequence message, not only a clean one. A receiver that acknowledges clean messages but silently drops a corrected result is the failure mode that matters clinically, and it will not appear in a happy-path demo. Record the result of that test against the interface row so the map becomes evidence rather than a diagram.

When any legacy endpoint remains in the path, the map will show a mixed estate: some rows FHIR, some rows feed-based. That is expected and manageable, provided each row carries its own owner, contract, and acknowledgment test point. The map is what makes the build/buy decision concrete, because it tells you exactly how many contracts you are asking a product or a team to own.

![How FHIR and Legacy Interfaces Move Data — Healthcare Communication Standards](https://static.mm-ais.com/article-images-ai/healthcare-communication-standards-hl7-f-ai-e01d0c93.jpg)

## What the Evidence Says About Failure

The convergence of communication failure as a safety and financial driver is documented across four independent sources. The Joint Commission, as summarized through cloud.pnb.org, identifies communication failures as the leading root cause of sentinel events. A PMC rapid review (PMC10464255) found that effective communication supports positive patient-centred outcomes, though the reviewed studies carried methodological setbacks that limit generalizability — to verify the study count and details, check the article directly. Forbes (Sep 8, 2025) translates this risk into tangible terms, reporting that loss of trust from poor communication translates to healthcare dollars and cents. Meanwhile, dhinsights.org (Feb 16, 2026) quantifies the scale: a survey of 1,000 patients estimates the cost of poor patient communication at $150 billion annually, driven by no-shows, missed bills, and life-threatening health consequences.

These figures are not abstract; they map directly to the integration choices ambulatory and lab leaders face. When legacy endpoints remain unconnected, the risk of field-level failure compounds. The available sources evidence establishes that communication failure is a leading safety and cost risk, but it contains no FHIR-specific benchmark. This gap means leaders cannot rely on generic data alone to justify a custom build. Instead, the evidence supports a defensible middle path: acquire a tested interface engine and build only the mapping and a 20-message test pack. This approach targets the documented risk zones without reinventing the transport layer.

The financial calculus is stark. The $150 billion figure from dhinsights.org represents the aggregate cost of poor communication across the system. For a single organization, the Joint Commission’s finding that communication is the leading root cause implies that every unvalidated interface is a potential sentinel event. Forbes confirms that the cost of lost trust is measurable in dollars. A custom-built FHIR gateway, lacking the proven acknowledgment and error-handling cycles of a commercial engine, shifts the entire burden of validation onto the mapping layer. By contrast, buying a tested engine and building only the mapping and a 20-message test pack isolates the variable cost to the domain-specific logic, where the actual clinical risk resides.

Leaders should treat the 20-message test pack as the go/no-go gate. The grounding establishes that communication failure is a leading safety and cost risk, but it contains no FHIR-specific field-failure benchmark, so the 2% threshold is an internal operating rule the organization sets for itself — not a figure derived from the Joint Commission safety data or the $150 billion communication cost estimate. With 20 messages, 2% is 0.4 of a message, so the working rule is zero failed messages; one failure is 1/20 = 5%, above the threshold. Write the threshold down before the first run so the hold decision is mechanical, and treat it as your own risk tolerance, not an external standard.

![What the Evidence Says About Failure — Healthcare Communication Standards](https://static.mm-ais.com/article-images-pixabay/healthcare-communication-standards-hl7-f-1c5864f6.jpg)

## Build vs Buy: Winner by Failure Mode

When you put the three procurement paths side by side, the comparison is less about technology preference and more about where you are willing to carry failure risk. A custom FHIR gateway gives your team the highest control over behavior, but it also puts the full mapping burden on your staff and concentrates failure risk in code your organization has to maintain. A bought interface engine or FHIR module shifts most transport and protocol handling to a vendor, lowering the mapping burden, but it leaves you with medium control and medium failure risk because configuration quality still varies by implementation. The hybrid path—buy the interface engine and build only the mapping and a 20-message test pack—lands at medium-high control, medium mapping burden, and low failure risk. That is the winner this section establishes for 2026 ambulatory and lab leaders: buy the engine, build the mapping and test pack.

| Path | Control | Mapping burden | Failure risk |
| --- | --- | --- | --- |
| Build custom FHIR gateway | High | High | High |
| Buy interface engine/module | Medium | Low | Medium |
| Hybrid: buy engine + build mapping/test pack | Medium-high | Medium | Low |

The check that makes the table operational is simple: name every endpoint you must support, then mark which ones are legacy. If any legacy endpoint remains on the list, the hybrid path is the defensible choice. You are not buying a black box and trusting it; you are buying the tested engine and keeping the part that requires local knowledge—the field-by-field mapping—in your own hands. The 20-message test pack is the proof object, not a formality. It is where you confirm that the mapping behaves as intended before you expand scope.

Custom building earns a place only under a narrower condition: no legacy endpoint remains. In that setting, the high mapping burden and high failure risk of a homegrown gateway can be weighed against the control gain, because you are no longer compensating for mixed generations of systems. With any legacy endpoint present, the same build path asks your team to solve both the modern interface problem and the translation problem at once. That is the failure mode the hybrid path avoids by separating the two.

This ranking is consistent with the direction of the evidence without claiming more than the evidence supports. The Joint Commission, as summarized through cloud.pnb.org, identifies communication failures as a leading root cause in sentinel events, and the broader literature summarized by the Australian Commission on Safety and Quality in Health Care frames communicating for safety as accurate, timely exchange across professionals, teams, patients, and support people. Those findings justify treating interface design as a safety decision. They do not, by themselves, establish a FHIR-specific benchmark for one vendor or one build pattern, so the decision has to rest on the failure-mode comparison above and on your own test pack results.

Use the rule this way in a 2026 review: start from the endpoint inventory, select the hybrid path whenever a legacy endpoint appears, and reserve custom build for the all-modern case. Then make the 20-message test pack the gate for release. If the pack exposes field-level failures, the answer is to correct the mapping and rerun the pack—not to assume the engine choice alone resolved the risk. That is how you keep the safety argument and the procurement argument aligned.

![Build vs Buy: Winner by Failure Mode — Healthcare Communication Standards](https://static.mm-ais.com/article-images-pixabay/healthcare-communication-standards-hl7-f-dafc51cc.jpg)

## Costs You Must Put in the Decision

The Joint Commission’s sentinel event data, as summarized through cloud.pnb.org, identifies communication failures as the leading root cause of serious safety events, making this risk a non-negotiable line item in any build-or-buy calculus. Curogram reports that poor communication can cost clinics thousands of dollars per year in avoidable losses, and that integration technology is a primary mechanism for stopping those leaks before they escalate. ClinicianCore’s analysis adds the hidden liability of fragmented communication, tying it directly to financial losses, malpractice exposure, revenue leakage, and clinician burnout — costs that a rigid custom build often fails to surface until after go-live.

To make the decision defensible, you must fund four cost buckets rather than comparing license price in isolation. License and implementation costs cover the base subscription or on-prem deployment. Mapping hours reflect the labor required to translate your specific clinical data fields into the engine’s format. Interface maintenance hours account for ongoing monitoring, error resolution, and version management as vendor APIs evolve. Downtime and fallback costs capture the revenue and safety impact when the connection fails; this bucket is often omitted in vendor quotes but is where the real financial exposure lives.

Every vendor you evaluate must produce three numbers on demand. First, the observed test-pack pass rate from a 20-message integration test; this is the single best predictor of go-live stability. Second, the monthly interface maintenance hour estimate, so you can staff or budget accordingly. Third, the downtime/fallback cost model, which should quantify the per-hour or per-incident financial impact if the connection drops. If a vendor cannot supply these three data points, the deal should stall until they can, because opaque cost structures almost always mask the integration risk you are trying to mitigate.

This section sets the boundary of the claim: the grounding establishes communication failure as a leading safety and cost risk, but it contains no FHIR-specific field-failure threshold or interface return figure, so those remain internal criteria each organization must set and verify through its own test pack. The section does not rank vendors or certify conformance. The limit is not a judgment against buying; it is a statement about what the available evidence can and cannot support for the 2026 decision.

| Edge case | Custom build may win | Buy path |
| --- | --- | --- |
| No legacy endpoint and in-house test lab | Yes | Buy still wins if vendor test pack passes |
| Critical result only by fax | No | Buy engine alone insufficient; buy engine plus build acknowledgment still wins |
| Vendor refuses test pack | Not buy | Build only if you can run the 20-message test pack |

In the no-legacy-endpoint and in-house test lab case, a custom build may win, but the buy path still wins if the vendor test pack passes. In the critical-result-only-by-fax case, a bought engine alone may be insufficient, and the buy engine plus build acknowledgment path still wins. If the vendor refuses the test pack, the instruction is not to buy; build only if the organization can run the 20-message test pack itself.

The decision check should therefore stay procedural. The leader should ask whether the vendor test pack is available and meaningful, whether the mapping can be built, and whether the failure mode justifies custom development. The evidence does not provide a FHIR-specific field-failure threshold or interface return figure, so those remain internal criteria.

![Costs You Must Put in the Decision — Healthcare Communication Standards](https://static.mm-ais.com/article-images-pixabay/healthcare-communication-standards-hl7-f-ebf83e0f.jpg)

## 20-Message Test Pack

The 20-message test pack is the gate that decides whether custom-building a FHIR gateway is safe. Assemble a sample of 20 messages — 8 admissions, 7 lab results, and 5 discharges — and run each through the candidate interface engine. For every message, capture the same four required fields: patient ID, order ID, result/status, and acknowledgment. Keep the sample fixed; if you change the mix, you invalidate the comparison.

Set the pass rule before you send the first message: a batch passes only at ≤2% failure. With 20 messages, 2% is 0.4 of a message, so the working rule is zero failures. One failed message is 1/20 = 5%, which is above the 2% threshold, and the batch is held. State the rule once, in writing, so the hold is a mechanical decision rather than a judgment call.

The worksheet has five steps: (1) generate the 20 messages across the three types; (2) log the four required fields for each; (3) run the three checkpoint checks below; (4) convert each check to a rate and compare it to 2%; (5) hold the batch if any checkpoint exceeds 2% and release only when all three are at or under the threshold. Record the counts and rates in the same worksheet every run so trends stay visible.

| Checkpoint | Result | Verdict |
| --- | --- | --- |
| Field completeness (4 required fields) | 19/20 = 95% | Fail (5% missing > 2%) |
| Acknowledgment | 18/20 = 90% | Fail (10% missing > 2%) |
| Duplicate detection | 20/20 = 100% | Pass |
| Overall batch | — | Hold (two checkpoints exceed 2%) |

Read the table as a hold, not a near-miss. Field completeness at 19/20 = 95% means 5% of messages are missing a required field, above 2%; acknowledgment at 18/20 = 90% means 10% of messages were not acknowledged, also above 2%; only duplicate detection at 20/20 = 100% passes. Two checkpoints exceed the threshold, so the batch is held. If the test pack shows ≤2% field failure, you have the evidence to consider a custom gateway; if it does not, keep the bought engine and fix the mapping.

The cost of being wrong runs both ways. Build the gateway before the test pack passes and you rework the mapping against a live system and push out the go-live. Release on a failing batch and the failed messages reach the receiving system — the failure mode the Australian Commission on Safety and Quality in Health Care's Communicating for Safety Standard is written to address, since it calls for accurate and timely exchange of information (safetyandquality.gov.au). The test pack is the cheap side of that trade; rework and a missed acknowledgment sit on the expensive side.

![20-Message Test Pack — Healthcare Communication Standards](https://static.mm-ais.com/article-images-pixabay/healthcare-communication-standards-hl7-f-1afb29eb.jpg)

## Five If/Then Rules for 2026

This section states the five if/then decision rules for 2026. Use them as gates, not as preferences. Each rule tells you what to do when a specific condition appears in your environment, and each one keeps the build/buy decision tied to evidence you can produce during review rather than to a vendor claim or an internal preference.

If the 20-message test pack exceeds 2% field failure, then hold the batch and do not sign the build/buy decision. This is the hard stop. A failed field is not a cosmetic mapping issue when the same field can carry a result, an order detail, or patient context. The Joint Commission, summarized through cloud.pnb.org, identifies communication failures as the leading root cause of sentinel events, and the 2026 safety and cost material from the Australian Commission on Safety and Quality in Health Care, Forbes, dhinsights.org, and the PMC rapid review all point in the same direction: communication quality affects safety, trust, and cost. A test pack that misses the field threshold gives you no basis to approve the architecture.

If the 20-message test pack shows field failure at or below 2%, then you may advance the build/buy decision, but only with the mapping and test pack as the evidence record. Do not treat a clean run as permission to expand scope into a custom FHIR gateway. The clean run answers the narrow question the pack was built to answer: whether the selected engine and your mappings preserve the fields you chose to test. Keep the result attached to that exact mapping version and that exact endpoint set.

If a vendor cannot show a named conformance test pack, then score it as unverified and require a paid pilot before purchase. “Named” means you can identify the pack, inspect what it tests, and connect the result to the interface behavior you are buying. Without that, the vendor has given you an assertion rather than evidence. Given the cost and safety concerns documented by Forbes, dhinsights.org, and the communication-failure material summarized from the Joint Commission, an unverified claim should not sit in the same category as a demonstrated result.

If the pilot still cannot produce a named conformance test pack and a repeatable field-level result, then keep the decision open and stay with the tested-engine path rather than committing to a custom build. That sequence — buy the engine, build the mapping and test pack, stop on a failed threshold, require proof before purchase — is the same rule priced in the Build vs Buy section above, and it gives ambulatory and lab leaders a decision they can defend when the question is not which architecture sounds modern, but which one can show that the message arrived intact.

## Frequently Asked Questions

**What is the leading safety and cost risk in healthcare according to the Communicating for Safety Standard?**

Communication failure is the leading safety and cost risk in healthcare, with the Communicating for Safety Standard identifying accurate and timely exchange as critical and failure directly endangering patients.

**How much can poor communication cost clinics annually per Curogram?**

Curogram reports that poor communication can cost clinics thousands of dollars per year in avoidable losses.

**What financial and legal risks does ClinicianCore link to fragmented clinical communication?**

ClinicianCore documents that fragmentation causes financial losses, revenue leakage, and increased malpractice exposure.

**When should an organization buy an interface engine rather than custom-build a FHIR gateway?**

Buy an interface engine and build only mapping and test pack when any legacy endpoint remains; do not custom-build a FHIR gateway unless the test pack shows ≤2% field failure.

**What should be built in-house when a legacy endpoint remains active?**

Build only the mapping and 20-message test pack when any legacy endpoint remains active.

**Who is the build-or-buy decision framework intended for?**

The framework is for 2026 ambulatory and lab leaders navigating HL7 FHIR integration with legacy systems.

## Quick answers

| What is the primary risk associated with communication failure in healthcare according to the article? | Communication failure is the leading safety and cost risk in healthcare, directly endangering patients. |
| --- | --- |
| What financial impact does poor communication have on clinics as reported by Curogram? | Poor communication can cost clinics thousands of dollars per year in avoidable losses. |
| What are the consequences of fragmented clinical communication according to ClinicianCore? | Fragmented clinical communication drives revenue leakage and malpractice risk, causing financial losses and increased malpractice exposure. |
| Under what condition should an organization buy an interface engine and build only a mapping/test pack? | An organization should buy an interface engine and build only the mapping and test pack when any legacy endpoint remains active. |
| When is it advised not to custom-build a FHIR gateway? | Do not custom-build a FHIR gateway unless the test pack shows a field failure rate of 2% or less. |

Also worth reading: **Lab Safety Operations Guide: CLIA-101 Protocol vs 2% QC Failure Trigger**: [Lab Safety Operations Guide: CLIA-101](https://hygiea.tech/blog/lab-safety-operations-guide-clia-101-protocol-vs-2-qc-failure-trigger.php) · **Lab turnaround goals: 2026 HL7 FHIR (Fast Healthcare Interoperability Resources) vs 25% error cap — Build or Buy**: [Lab turnaround goals: 2026 HL7](https://hygiea.tech/blog/lab-turnaround-goals-2026-hl7-fhir-fast-healthcare-interoperability-resources-vs-25-error-cap-build-or-buy.php)

### Related reading

- [Waived-test competency records: verify CLIA checklist and compare like-for-like](https://hygiea.tech/blog/waived-test-competency-records-verify-clia-checklist-and-compare-like-for-like.php)
- [Lab Safety Operations Guide: CLIA-101 Protocol vs 2% QC Failure Trigger](https://hygiea.tech/blog/lab-safety-operations-guide-clia-101-protocol-vs-2-qc-failure-trigger.php)
- [Early Breast Cancer Spread Risk: 70-Gene MammaPrint to Skip Chemo in 46%](https://hygiea.tech/blog/early-breast-cancer-spread-risk-70-gene-mammaprint-to-skip-chemo-in-46.php)
- [CLIA PT Corrective Action Deferral: Verify Delay Risks Before You Commit](https://hygiea.tech/blog/clia-pt-corrective-action-deferral-verify-delay-risks-before-you-commit.php)
- [CLIA waived testing errors: 30-day fix window vs 2% QC trigger in family medicine](https://hygiea.tech/blog/clia-waived-testing-errors-30-day-fix-window-vs-2-qc-trigger-in-family-medicine.php)
- [Lab turnaround goals: 2026 HL7 FHIR (Fast Healthcare Interoperability Resources) vs 25% error cap — Build or Buy](https://hygiea.tech/blog/lab-turnaround-goals-2026-hl7-fhir-fast-healthcare-interoperability-resources-vs-25-error-cap-build-or-buy.php)

### Latest

- [Waived-test competency records: verify CLIA checklist and compare like-for-like](https://hygiea.tech/blog/waived-test-competency-records-verify-clia-checklist-and-compare-like-for-like.php)
- [Lab Safety Operations Guide: CLIA-101 Protocol vs 2% QC Failure Trigger](https://hygiea.tech/blog/lab-safety-operations-guide-clia-101-protocol-vs-2-qc-failure-trigger.php)
- [Early Breast Cancer Spread Risk: 70-Gene MammaPrint to Skip Chemo in 46%](https://hygiea.tech/blog/early-breast-cancer-spread-risk-70-gene-mammaprint-to-skip-chemo-in-46.php)

Canonical: https://hygiea.tech/blog/healthcare-communication-standards-hl7-fhir-vs-legacy-systems-build-or-buy-decision-guide-2026.php
Markdown: https://hygiea.tech/blog/healthcare-communication-standards-hl7-fhir-vs-legacy-systems-build-or-buy-decision-guide-2026.php/index.md

```json
{"@context":"https://schema.org","@type":"BlogPosting","headline":"Healthcare Communication Standards: HL7 FHIR vs Legacy Systems — Build or Buy Decision Guide 2026","url":"https://hygiea.tech/blog/healthcare-communication-standards-hl7-fhir-vs-legacy-systems-build-or-buy-decision-guide-2026.php","description":"Takeaway Detail Communication failure is the leading safety and cost risk in healthcare The Communicating for Safety Standard identifies accurate and timely exc","datePublished":"November 19, 2026","author":{"@type":"Person","name":"Dr. Nadia Petrov"},"articleBody":"| Takeaway | Detail | | --- | --- | | Communication failure is the leading safety and cost risk in healthcare | The Communicating for Safety Standard identifies accurate and timely exchange as critical; failure directly endangers patients | | Poor communication costs clinics thousands annually | Curogram reports that poor communication can cost clinics thousands of dollars per year in avoidable losses | | Fragmented clinical communication drives revenue leakage and malprac..."}
```
